Remove DNA Remove Small Molecule Remove Virus
article thumbnail

The untapped potential of the transcriptome  

Drug Discovery World

DDW’s Megan Thomas speaks to Khan about the work her team is doing to create the first map of the druggable transcriptome, which involves understanding RNA biology to discover small molecule drugs. Understanding how RNA structure is linked to function would open up entirely new target space for the small molecule modality.

article thumbnail

Conversations from ESMO Targeted Anticancer Therapies Congress 2024 

Drug Discovery World

More importantly, it also highlighted that significant challenges remain in selecting the right therapies for the right patients despite the progress made through genomic testing and implementation of circulating tumour (ct) DNA analyses. We were there to present the latest findings from our research.

Therapies 162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lipid nanoparticles and mRNA used to treat hereditary blindness

Drug Discovery World

The peptides that we have discovered can be used as targeting ligands directly conjugated to silencing RNAs, small molecules for therapeutics or as imaging probes,” Herrera-Barrera added. . “We used these peptides to act as zip codes to deliver nanoparticles carrying genetic materials to the intended address within the eye.” .

article thumbnail

Chemoproteomics Identifies State-Dependent and Proteoform-Selective Caspase-2 Inhibitors

Covalent Modifiers

Complementary to genetic approaches, small-molecule probes have emerged as useful tools for modulating caspase activity. However, due to the high sequence and structure homology of all 12 human caspases, achieving selectivity remains a central challenge for caspase-directed small-molecule inhibitor development efforts.

article thumbnail

Phages could help to tackle antimicrobial resistance

Drug Target Review

In an infected animal, cGAS senses viral DNA in cytoplasm whilst in an uninfected organism, DNA is confined in the nucleus. Bacteria must take a different approach as they do not have nuclei and if CBASS reacted to the presence of DNA, it would cause autoimmunity or the bacterium to attack itself, Banh said. But what, exactly?”

RNA 59
article thumbnail

Eight announcements to expect at AACR 2023   

Drug Discovery World

As such, Codagenix has previously demonstrated that CodaLytic, a codon-modified influenza virus, can kickstart the cancer immunity cycle at various steps in several mouse models with differing baseline immune contextures.

Virus 130
article thumbnail

Global advances in synthetic biology

Drug Discovery World

It is believed that the term synthetic biology was created in 1970 by geneticist, Waclaw Szybalski 1 as work was being carried out on the development of DNA sequencing and synthesis techniques. These factors can significantly contribute to the growth of the synthetic biology market, it adds. . Brady and colleagues turned to algorithms.